Louie Ngar Yee - 27 Jul 2022 Form 3 Insider Report for MAIA Biotechnology, Inc. (MAIA)

Role: Director, 10%+ Owner
Signature: /s/ Louie Ngar Yee
Issuer symbol: MAIA
Transactions as of: 27 Jul 2022
Net transactions value: $0
Form type: 3
Filing time: 27 Jul 2022, 18:34:56 UTC
Next filing: 02 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	MAIA	Common Stock						908,584	27 Jul 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	18,000	$1.80	Direct	F2
holding	MAIA	Stock Options							27 Jul 2022	Common Stock	28,000	$10.00	Direct	F3
holding	MAIA	Warrants							27 Jul 2022	Common Stock	86,292	$6.00	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Ms. Louie beneficially owns 908,584 shares of common stock.
F2	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vested in 12 equal monthly instalments beginning on November 15, 2020.
F3	Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vest in 12 equal monthly installments beginning on November 15, 2021.
F4	Each Warrant became exercisable on the date of issuance of February 26, 2021, and expires on the earliest to occur of: (a) February 25, 2028, or (b) immediately prior to the closing of any change of control.